deltatrials
Completed NA INTERVENTIONAL 2-arm NCT01966159

The EVOLVE China Clinical Trial (EVOLVE-CHINA)

EVOLVE China: A Prospective, Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)

Sponsor: Boston Scientific Corporation

Conditions Coronary Artery Disease
Interventions PE Plus Investigational Device SYNERGY Investigational Device
Updated 13 times since 2017 Last updated: Nov 13, 2023 Started: Oct 31, 2013 Primary completion: Jul 31, 2014 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Boston Scientific Corporation and has accumulated 13 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Jul 2017 · 2 months · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Mar 2019 · 9 months · monthly snapshot~Mar 2019 – ~Aug 2020 · 17 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Dec 2022 · 22 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Dec 2023 · 11 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2023 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2023 — Dec 2023 [monthly]

    Completed NA

  5. Dec 2022 — Jan 2023 [monthly]

    Completed NA

▶ Show 8 earlier versions

  1. Feb 2021 — Dec 2022 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  2. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting NA

  3. Aug 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  4. Mar 2019 — Aug 2020 [monthly]

    Active Not Recruiting NA

  5. Jun 2018 — Mar 2019 [monthly]

    Active Not Recruiting NA

  6. Jul 2017 — Jun 2018 [monthly]

    Active Not Recruiting NA

  7. May 2017 — Jul 2017 [monthly]

    Active Not Recruiting NA

    Phase: PHASE3 → NA

  8. Jan 2017 — May 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Scientific Corporation
Data source: Boston Scientific Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations